News & Updates

Show Multimedia Only
COVID-19 vaccines weaker in liver transplant recipients, CLD patients

COVID-19 vaccines weaker in liver transplant recipients, CLD patients

19 Nov 2021 byTristan Manalac

Vaccines against the coronavirus disease 2019 (COVID-19) induce weaker and more transient immune responses in liver transplant recipients, those with cirrhosis, or those with chronic liver disease (CLD), according to a study presented at The Liver Meeting Digital Experience 2021 by the American Association for the Study of Liver Diseases (AASLD 2021).

19 Nov 2021
Liver injury persists in patients with vaccine breakthrough COVID-19

Liver injury persists in patients with vaccine breakthrough COVID-19

18 Nov 2021 byStephen Padilla

Liver injury is not uncommon among patients with vaccine breakthrough COVID-19, indicating the importance of monitoring liver injury enzymes, according to a study presented at The Liver Meeting 2021 by the American Association for the Study of Liver Diseases (AASLD 2021).

18 Nov 2021